This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Correction: Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications

Published: June 15, 2011

Correction

In the article “Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications” by Ni A. Khin, MD, and colleagues published in the April 2011 issue (J Clin Psychiatry 2011;72[4]:464-472), the legend for Figures 1, 2A, and 3 has been corrected online to “△ Trial with mean baseline HDRS score < 20” and “■  Trial with mean baseline HDRS score ≥ 20″; and the legend for Figure 2B has been corrected to “■  Trial with mean baseline HDRS score ≥ 20.” The staff regret the errors.

Volume: 72

Quick Links: Depression (MDD)

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression

Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived...

Read More...